Strategic News Watch • July 31, 2026 Daily Biopharma Digest – July 31, 2026 July 31, 2026 Novo Nordisk’s anti-inflammatory heart drug ziltivekimab failed its… Membership Required You must be a member to access this content. View Membership Levels Already a member? Log in here